Predict your next investment

Corporation
incandco.com

See what CB Insights has to offer

Portfolio Exits

1

About Inc & Co

Inc & Co focuses on building a dynamic portfolio and offers its companies business development, financial and HR support across the group.

Inc & Co Headquarter Location

Manchester, England,

United Kingdom

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Latest Inc & Co News

Injectable Nanomedicines Market 2021 | Key Segment Analysis, Business Growth Prospect, Research with Covid-19 Breakdown- Merck & Co., Inc., Osartis GmbH & Co. KG, Wyeth Pharmaceuticals Inc

Oct 25, 2021

Injectable Nanomedicines market players – Merck & Co., Inc., Osartis GmbH & Co. KG, Wyeth Pharmaceuticals Inc., Orthovita, Inc., Novartis, Abbott, Pacira Pharmaceuticals, QLT Phototherapeutics, Celgene Pharmaceutical Co. Ltd, among others represent the global Injectable Nanomedicines market. The market study depicts an extensive analysis of all the players running in the Injectable Nanomedicines market report based on distribution channels, local network, innovative launches, industri...

Inc & Co Portfolio Exits

1 Portfolio Exit

Inc & Co has 1 portfolio exit. Their latest portfolio exit was MyLife Digital on April 21, 2021.

Date

Exit

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Acquirer

Sources

4/21/2021

Acquired - II

2

Date

4/21/2021

Exit

Acquired - II

Companies

Valuation

Acquirer

Sources

2

Inc & Co Acquisitions

10 Acquisitions

Inc & Co acquired 10 companies. Their latest acquisition was Baldwins Travel on September 16, 2021.

Date

Investment Stage

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Total Funding

Note

Sources

9/16/2021

Acquired

1

8/4/2021

Acquired

1

8/17/2020

Acquired

$10.01M

Acquired

1

8/11/2020

Subscribe to see more

$99M

Subscribe to see more

10

8/5/2020

Subscribe to see more

$99M

Subscribe to see more

10

Date

9/16/2021

8/4/2021

8/17/2020

8/11/2020

8/5/2020

Investment Stage

Acquired

Companies

Subscribe to see more

Subscribe to see more

Valuation

Total Funding

$10.01M

$99M

$99M

Note

Acquired

Acquired

Acquired

Subscribe to see more

Subscribe to see more

Sources

1

1

1

10

10

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.